Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Darragh

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
Biopharmaceutics & Drug Disposition|April 1, 1985
Bioequivalence of a sustained-release isosorbide dinitrate formulation at steady-stateT Taylor, L F Chasseaud, R M Major, et al.
Arzneimittel-Forschung|January 1, 1984
[Bioavailability of isosorbide-5-mononitrate from delayed-action formulations]T Taylor, R M Major, F C Leaf, et al.
Antiviral Research|October 1, 1987
Tolerance and nasal histopathologic effects of long-term, low-dose intranasal recombinant interferon alpha-2A (Roferon-A)F G Hayden, S E Mills, D J Innes, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1982
Metabolic fate of the beta-blocker 14C-bupranolol in humans, dogs, and rhesus monkeysA R Waller, L F Chasseaud, R Bonn, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 1, 1981
The metabolic fate of 3[H]econazole in manI Midgley, P J van Bladeren, D R Hawkins, et al.
Journal of Pharmacobio-Dynamics|December 1, 1982
The metabolic fate of 11-bromo-[15-3H] vincamine in rats, dogs and humansB C Mayo, S R Biggs, D R Hawkins, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 1, 1987
Metabolic fate of the thrombolytic agent benzarone in man: comparison with the rat and dogS G Wood, B A John, L F Chasseaud, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 1, 1985
Metabolism and pharmacokinetics of the dihydropyridine calcium antagonist, ryosidine, in manI Midgley, L F Chasseaud, I W Taylor, et al.
British Journal of Clinical Pharmacology|January 1, 1979
Effect of beta-blockers on exercise double product (systolic blood pressure x heart rate)R A Vukovich, J E Foley, B Brown, et al.
Arzneimittel-Forschung|January 1, 1984
Metabolic fact of 14C-isosorbide 5-mononitrate in humansS G Wood, B A John, L F Chasseaud, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Biopharmaceutics & Drug Disposition|April 1, 1985
Bioequivalence of a sustained-release isosorbide dinitrate formulation at steady-stateT Taylor, L F Chasseaud, R M Major, et al.
Arzneimittel-Forschung|January 1, 1984
[Bioavailability of isosorbide-5-mononitrate from delayed-action formulations]T Taylor, R M Major, F C Leaf, et al.
Antiviral Research|October 1, 1987
Tolerance and nasal histopathologic effects of long-term, low-dose intranasal recombinant interferon alpha-2A (Roferon-A)F G Hayden, S E Mills, D J Innes, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1982
Metabolic fate of the beta-blocker 14C-bupranolol in humans, dogs, and rhesus monkeysA R Waller, L F Chasseaud, R Bonn, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 1, 1981
The metabolic fate of 3[H]econazole in manI Midgley, P J van Bladeren, D R Hawkins, et al.
Journal of Pharmacobio-Dynamics|December 1, 1982
The metabolic fate of 11-bromo-[15-3H] vincamine in rats, dogs and humansB C Mayo, S R Biggs, D R Hawkins, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 1, 1987
Metabolic fate of the thrombolytic agent benzarone in man: comparison with the rat and dogS G Wood, B A John, L F Chasseaud, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 1, 1985
Metabolism and pharmacokinetics of the dihydropyridine calcium antagonist, ryosidine, in manI Midgley, L F Chasseaud, I W Taylor, et al.
British Journal of Clinical Pharmacology|January 1, 1979
Effect of beta-blockers on exercise double product (systolic blood pressure x heart rate)R A Vukovich, J E Foley, B Brown, et al.
Arzneimittel-Forschung|January 1, 1984
Metabolic fact of 14C-isosorbide 5-mononitrate in humansS G Wood, B A John, L F Chasseaud, et al.
Pageof 11